Document Detail

Diastolic Dysfunction in Patients With End-Stage Liver Disease is Associated With Development of Heart Failure Early After Liver Transplantation.
MedLine Citation:
PMID:  22918216     Owner:  NLM     Status:  Publisher    
BACKGROUND: Liver transplantation (LTx) is a life-saving treatment of end-stage liver disease. Cardiac complications including heart failure (HF) are among the leading causes of death after LTx. THE AIM: The aim is to identify clinical and echocardiographic predictors of developing HF after LTx. METHODS: Patients who underwent LTx at the University of Nebraska Medical Center (UNMC) between January 2001 and January 2009 and had echocardiographic study before and within 6 months after transplantation were identified. Patients with coronary artery disease (>70% lesion) were excluded. HF after LTx was defined by clinical signs, symptoms, radiographic evidence of pulmonary congestion, and echocardiographic evidence of left ventricular dysfunction (left ventricle ejection fraction <50%). RESULTS: Among 107 patients (presented as mean age [SD], 55 [10] years; male, 70%) who met the inclusion criteria, 26 (24%) patients developed HF after LTx. The pre-LTx left ventricle ejection fraction did not differ between the HF (69 [7]) and the control groups (69 [7] vs. 67 [6], P=0.30). However, pre-LTx elevation of early mitral inflow velocity/mitral annular velocity (P=0.02), increased left atrial volume index (P=0.05), and lower mean arterial pressure (P=0.03) were predictors of HF after LTx in multivariate analysis. Early mitral inflow velocity/mitral annular velocity greater than 10 and left atrial volume index 40 mL/m2 or more were associated with a 3.4-fold (confidence interval, 1.2-9.4; P=0.017) and 2.9-fold (confidence interval, 1.1-7.5; P=0.03) increase in risk of development of HF after LTx, respectively. CONCLUSIONS: This study suggests that elevated markers of diastolic dysfunction during pre-LTx echocardiographic evaluation are associated with an excess risk of HF and may predict post-LTx survival.
Taylor F Dowsley; David B Bayne; Alan N Langnas; Ioana Dumitru; John R Windle; Thomas R Porter; Eugenia Raichlin
Related Documents :
17714066 - Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiestera...
12440556 - Beta-blockers in chronic heart failure: considerations for selecting an agent.
7919586 - Primary and secondary prevention of ischemic heart disease.
22429696 - Could successful cryoballoon ablation of paroxysmal atrial fibrillation prevent progres...
15494776 - Real-time dobutamine stress myocardial contrast echocardiography for detecting coronary...
7680456 - Extended protocol for demonstration of dual av nodal physiology.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-22
Journal Detail:
Title:  Transplantation     Volume:  -     ISSN:  1534-6080     ISO Abbreviation:  Transplantation     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0132144     Medline TA:  Transplantation     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 Division of Cardiology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE. 2 Section of Transplantation, Department of Surgery, University of Nebraska Medical Center, Omaha, NE. 3 Address correspondence to: Eugenia Raichlin, M.D., Division of Cardiology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 69198-2265.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Risk Factors of Local Oropharyngeal and Laryngeal Adverse Effects from Use of Single Inhaled Cortico...
Next Document:  CKD-EPI Instead of MDRD for Candidates to Kidney Donation.